Proteins

Items 1-10 of 31

Page
per page
Set Descending Direction
  1. ANGPTL7 (human) (rec.)
    AG-40A-0060
    AG-40A-0060-C01010 µg
    CHF 265.00
    AG-40A-0060-C05050 µg
    CHF 790.00
    ERK phosphorylation induced by hANGPTL7 in THP-1 cells.
THP-1 monocyte cells were serum starved for 16hr and then stimulated with ANGPTL7 (human) (rec.) (Prod. No. AG-40A-0060) (500ng/ml) for 1, 2 and 3 hrs, respectively. Antibodies against pERK1/2
  2. BMP-2 (human) (rec.) (His)
    CHI-HR-200BMP2
    CHI-HR-200BMP2-C01010 µg
    CHF 210.00
    CHI-HR-200BMP2-C05050 µg
    CHF 600.00
  3. BMP-2 (human):Fc (human) (rec.) (non-lytic)
    CHI-HF-220BMP2
    CHI-HF-220BMP2-C05050 µg
    CHF 490.00
  4. CD38 (human) (rec.) (His) (active) (10µg)
    BBL-2275
    BBL-2275-C01010 µg
    CHF 782.00
    CD38 (human) (rec.) (His) (active) (10µg)
  5. DLK1 (mouse):Fc (human) (rec.)
    AG-40A-0107Y
    AG-40A-0107Y-C01010 µg
    CHF 290.00
    AG-40A-0107Y-30103 x 10 µg
    CHF 575.00
    Replaces AG-40A-0107
    DLK1 (mouse):Fc (human) (rec.)
  6. DLL1 (human) (rec.)
    AG-40A-0073
    AG-40A-0073-C01010 µg
    CHF 190.00
    AG-40A-0073-C05050 µg
    CHF 380.00
    Adipogenesis inhibition of MSCs.
MSCs (Mesenchymal stem cells) were maintained in DMEM, supplemented with 10% fetal bovine serum, penicilin-streptomycin and glutamine. For differentiation of MSCs, MSCs were cultured in adipogenic medium which was gr
  7. DLL1 (human):Fc (human) (rec.)
    AG-40A-0116Y
    AG-40A-0116Y-C01010 µg
    CHF 305.00
    AG-40A-0116Y-C05050 µg
    CHF 835.00
    Adipogenesis inhibition of 3T3L1 cells.3T3L1 cells were maintained in DMEM, supplemented with 10% fetal bovine serum, penicilin-streptomycin. Adipogenesis was initiated by adding 1μM dexamethasone, 0.5mM IBMX, 10μg/ml insulin (day 0) until day
  8. DLL1 (mouse):Fc (human) (rec.)
    AG-40A-0148Y
    AG-40A-0148Y-C01010 µg
    CHF 180.00
    AG-40A-0148Y-C05050 µg
    CHF 370.00
    DLL1 (mouse):Fc (human) (rec.)
  9. DLL4 (human):Fc (human) (rec.) (highly active mutant)
    AG-40B-0176
    AG-40B-0176-C01010 µg
    CHF 350.00
    AG-40B-0176-C100100 µg
    CHF 1'080.00
    DLL4 (human):Fc (human) (rec.) (highly active mutant) (AG-40B-0176) binds to mNotch1 with higher affinity than WT DLL4:Fc. Method: Notch1 (mouse):Fc was coated on an ELISA plate at 1μg/ml. After blocking and washing steps, indicated concentrations
  10. Fc (human):FLT3 Ligand (human) (rec.)
    AG-40B-0119
    AG-40B-0119-C01010 µg
    CHF 240.00
    AG-40B-0119-30103 x 10 µg
    CHF 480.00
    AG-40B-0119-C100100 µg
    CHF 960.00
    Influence of FLT3L treatment on lymphocyte subpopulations. Method: C57BL/6 mice were injected intraperitoneally with 10 μg daily or were left untreated. (A) Percentages of indicated splenic subpopulations in FLT3L KO, WT control or WT-treated mice.

Items 1-10 of 31

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.